SIGA Technologies (OTCMKTS:SIGA) was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Tuesday.

Shares of SIGA Technologies (OTCMKTS:SIGA) remained flat at $$4.90 during midday trading on Tuesday. The stock had a trading volume of 8,116 shares, compared to its average volume of 47,789. The company has a debt-to-equity ratio of -0.22, a current ratio of 3.14 and a quick ratio of 2.91. SIGA Technologies has a 52-week low of $2.56 and a 52-week high of $5.24.

ILLEGAL ACTIVITY WARNING: “SIGA Technologies (SIGA) Downgraded to “Sell” at ValuEngine” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/12/05/siga-technologies-siga-downgraded-to-sell-at-valuengine.html.

About SIGA Technologies

SIGA Technologies, Inc is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company’s lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield).

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for SIGA Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.